The present invention relates to a pharmaceutical composition, and to a food composition, for regulating intestinal motility, and more particularly, to a pharmaceutical composition, and to a food composition, which use a Chamaecyparis obtusa extract so as to be effective in the prevention and treatment of intestinal motility disorders. The pharmaceutical composition for regulating intestinal motility according to the present invention contains the Chamaecyparis obtusa extract as an active ingredient, wherein intestinal motility is regulated by varying the electrical activity of interstitial cells of Cajal. Further, the food composition for regulating intestinal motility according to the present invention contains the Chamaecyparis obtusa extract as an active ingredient.
